WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences solutions, announced the significant expansion of its pricing and market access offerings. Leading the function, newly named Evidence, Value, Access & Pricing (EVAP), is Senior Partner Monica Martin De Bustamante. Ms. Martin De Bustamante had joined Trinity in October 2021 through the acquisition of CBPartners, a company she founded.
The expanded team is made up of both functional experts as well as a talented pool of centralized staff who work across project types. The two segments include:
- Evidence Strategy – provides end-to-end evidence strategy and planning, execution of publication-grade studies and pull-through to scientific dissemination.
- Value, Access and Pricing – delivers innovative and locally-nuanced global solutions for value, market access and pricing development and execution support.
“Ensuring reimbursement and patient access to treatments is a multifaceted process. The newly expanded EVAP function within Trinity is designed to help clients sift through the complexity and achieve a clear path forward,” said Monica Martin de Bustamante, Senior Partner, Evidence, Value, Access & Pricing. “Our global expertise is supported by our knowledge resource hubs in the United States, Europe, Latin America, Middle East and North Africa and Asia-Pacific regions allowing us to provide best-in-class work for our clients in evidence generation, value demonstration, health economics/outcomes research (HEOR), access and pricing.”
About Trinity Life Sciences
Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.
